User claims he synthesized PAC-3310, a ChatGPT-designed schizophrenia drug, in his garage lab
SatelliteNetSec · x · 2026-09-09
A user (@DouglasYaoDY) claims ChatGPT designed a novel drug, PAC-3310, which he synthesized in a garage chemistry lab. He describes it as a selective M4 muscarinic receptor agonist for schizophrenia, similar to but improved over the recent breakthrough drug Cobenfry. The post went viral with jokes about ChatGPT prescribing medicine.
If accurate, it's a striking safety case: an AI-designed drug candidate synthesized and presumably self-administered without animal trials or clinical oversight — highlighting how AI lowers barriers to risky professional domains.
More from Fun
- Biologist has GPT-6 Astra design a custom pipette from scratch for 3D printing — DeryaTR_ · 2026-09-09
- Why you should catch up on Michael Levin's takes on intelligence — cephaloform · 2026-09-09
- AI circle meme: asking Sam Altman to fund the cat-ears peptide next — QuintinPope5 · 2026-09-09
- Devs turn a retired Meta Portal into a baby-care voice logger using gpt-realtime API — SIGKITTEN · 2026-09-09
- Everyone's still warming up to one agent; OpenAI is unleashing 10,000 on math nerds — msg · 2026-09-09
- Pedro Domingos: LLMs still can't add two numbers of arbitrary length — pmddomingos · 2026-09-09